Collaborative Ocular Melanoma Study (COMS)

The COMS is a multicenter randomized trial investigations - sponsored by The National Eye Institute and The National Cancer Institute - designed to evaluate therapeutic interventions for patients who have choroidal melanoma. The evaluations conducted in the COMS are aimed at determining which of two alternative therapies better prolongs the remaining lifetime of individuals diagnosed as having choroidal melanoma and, if two alternatives provide similar expectations of survival, to determine which offers the patient the longer cancer-free life and the better prognosis for vision overall.

Author(s): Paul Montague, University of Iowa Ophthalmology. Originator(s): National Eye Institute., National Cancer Institute., National Eye Institute
Resource added in: 09/10/2002
Available languages: English
Medulloblastoma, Astrocytoma, Ependymoma, Glioma, Craniopharyngioma, Pinealoma, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Drug Therapy, Radiotherapy, General Surgery, Pediatrics, Child, Adolescent, Neoplasms, Melanoma, Brachytherapy, Radiotherapy, General Surgery, Eye Enucleation, Clinical Protocols, Randomized Controlled Trials as Topic, Combined Modality Therapy, Clinical Trials Data Monitoring Committees, Research Groups, Neoplasmas Cerebrales, Neoplasmas de la Médula Espinal, Neoplasmas Cerebrales, Neoplasmas del Ojo, Neoplasmas de la Uvea, Neoplasmas de la Coroides, Ensayos Clínicos, Educación del Paciente, Estudios Multicéntricos
  • Share
  • Suggest tag
    Separated by comma
    Thank you for your suggestion.
    Communication problem. Please try again later.
  • Report error
    New Link (Optional)
    Thank you for your report.
    Communication problem. Please try again later.
comments powered by Disqus